December 4, 2020
NOT-OD-20-121 - Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NOT-OD-20-120 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NOT-OD-20-119 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NOT-OD-21-103 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)
NOT-OD-21-101 - Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake
NATIONAL INSTITUTES OF HEALTH (NIH)
The purpose of this notice is to update the terms and conditions of award for recipients of competitive revision awards under the RADx Underserved Populations (RADx-UP) initiative. This includes all awards issued in response to the following Notices of Special Interest:
This guide notice does not apply to awards issued outside of these NOSIs.
Multiple Program Director/Principal Investigator Requirements
Recipients are reminded that for competitive revisions to parent awards that include multiple PD/PIs, the supplement must align with the PD/PIs on the parent award. Recipients may add members to the leadership team outside of the named PD/PIs, to provide expertise needed for the supplemental activities; the contact PD/PI and Multi-PD/PIs may not differ from the parent award. Any changes to the PD/PIs must be submitted as a prior approval request, along with an updated leadership plan for the award.
In addition to the annual RPPR, recipients of awards issued in response to NOT-OD-20-119, NOT-OD-20-120 and NOT-OD-20-121 are required to submit an interim progress report every six months outlining key milestones that have been met.
Below are additional instructions on what NIH is requiring recipients of these NOSIs to submit as a part of their interim report.
Recipients will continue to report information on the competitive revision supplements in the annual RPPR, Section G.1, as directed by the current term of award, and must include updates to the information provided in the interim report (as outlined in the above bullets).
For supplements where the parent award is in an extension, and no further RPPRs are due, recipients must submit their annual reports, including budget information for the next year, using AM.
NIH expects recipients of awards issued in response to NOT-OD-20-121 and NOT-OD-20-120 to complete 75% of their milestones along with the accompanying budget within the first 12 months of the project. For these awards, in alignment with standard NIH terms and conditions, recipients maintain authority for automatic carryover of unobligated balances. NIH staff will regularly monitor drawdowns in the Payment Management System to determine whether there are large unobligated balances. Consistent with existing NIH discretion, awards may be offset where the recipient has not met performance and expenditure milestones.
Please direct grants policy inquiries to:
NIH Office of Policy for Extramural Research Administration
Division of Grants Policy
For questions regarding a specific grant award please contact the Grants Management Specialist identified in the Notice of Award.